Skip to main content
SpringerLink
Log in

Ciprofloxacin i.v.

Defining Its Role in Serious Infections

  • Conference proceedings
  • © 1994

Overview

Editors:
  1. Christopher Garrard

    1. John Radcliffe Hospital, Oxford, UK

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (12 papers)

  1. Front Matter

    Pages i-xii
    Download chapter PDF

  2. Effect of Quinolones Against Slowly Growing Bacteria

    • A. Dalhoff, S. Matutat, U. Ullmann
    Pages 1-12

  3. The Postantibiotic Effect of Ciprofloxacin

    • B. Wiedemann, B. Kratz
    Pages 13-19

  4. The Effects of Different Types of Antimicrobial Agents on Plasma Endotoxin Activity in Gram-Negative Bacterial Infection

    • D. Nitsche, C. Schulze, S. Oesser, A. Dalhoff, M. Sack
    Pages 21-38

  5. Dose-Finding Investigations of Intravenous Ciprofloxacin in a Pharmacodynamic Model

    • A. Bauernfeind, S. Kljucar
    Pages 39-48

  6. The Relationship Between Ciprofloxacin Blood Concentrations, MIC Values, Bacterial Eradication, and Clinical Outcome in Patients with Nosocomial Pneumonia

    • J. J. Schentag
    Pages 49-61

  7. Efficacy and Safety of Ciprofloxacin in Various Intravenous Dosages

    • S. Kljucar, M. Heimesaat, A. Bauernfeind, E. von Pritzbuer, J. Timm
    Pages 63-73

  8. Intravenous Ciprofloxacin Versus Imipenem/ Cilastatin in the Treatment of Severe Pneumonia

    • K. V. Leeper
    Pages 75-83

  9. Conversion from Intravenous to Oral Ciprofloxacin: Observing the “Like-to-Like” Phenomenon

    • C. H. Nightingale, P. P. Belliveau, R. Quintiliani
    Pages 85-95

  10. Therapeutic Use of Quinolones in Oncology

    • G. Maschmeyer
    Pages 97-108

  11. Ciprofloxacin in Neutropenic Host Infection

    • H. Giamarellou
    Pages 109-119

  12. Intravenous Ciprofloxacin for the Treatment of Lower Respiratory Tract Infections: Preliminary Results

    • P. Mangiarotti, C. Grassi
    Pages 121-130

  13. Integrated Safety Profile of Intravenous Ciprofloxacin

    • C. Reiter, M. Pfeiffer, R. Hullmann, P. Schacht
    Pages 131-146
Back to top

Keywords

About this book

On the occasion of a symposium in Salzburg, an international team of clinicians and pharmacologists presented recent results in profile efficacy, safety and therapeutic use of the antibiotic substance Ciprofloxacin. Of special interest for clinicians will be the clinical outcome in patients with nosocomial pneumonia and other infections of the lower respiratory tract.

Editors and Affiliations

  • John Radcliffe Hospital, Oxford, UK

    Christopher Garrard

Bibliographic Information

  • Book Title: Ciprofloxacin i.v.

  • Book Subtitle: Defining Its Role in Serious Infections

  • Editors: Christopher Garrard

  • DOI: https://doi.org/10.1007/978-3-642-79098-0

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1994

  • Softcover ISBN: 978-3-642-79100-0Published: 08 December 2011

  • eBook ISBN: 978-3-642-79098-0Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XIV, 146

  • Topics: Internal Medicine, Pharmacology/Toxicology

Publish with us

Policies and ethics

Back to top

Search

Navigation